Semaglutide 2.4 mg once weekly, a subcutaneously administered GLP-1 RA approved for obesity treatment in 2021, results in 1517% mean weight loss (WL) with evidence of cardioprotection
GLP-1 medications, including well-known options like Ozempic, Wegovy and Zepbound, help people manage their weight and conditions like type 2 diabetes by slowing digestion, reducing appetite and supporting blood sugar control
There is a faster track called Priority Review (6 months) for drugs that represent a major improvement over what is already available
The safety and effectiveness of Vyvanse for the treatment of obesity have not been established. Risks of Vyvanse for weight loss As Alex Foxman, MD, internist and medical director of Achieve Health and Weight Loss, emphasizes, Vyvanse is not a safe or effective way to lose weight outside of healthcare provider-guided binge eating disorder treatment
Once the medication is fully dispensed, hold the needle in place for several seconds before withdrawing and disposing of it in a designated sharps container
doi: 10.1056/NEJMoa1411892 93 WaddenTAHollanderPKleinSNiswenderKWooVHalePMet al
